A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. The analysis showed that TMLR was not an efficient instrument for the management of patients with severe coronary artery disease. Even under favouring assumptions, the estimated cost-utility ratio of TMLR was far above the threshold value widely accepted in the UK.